A Chemical-Intervention Strategy to Circumvent Peptide Hydrolysis by D-Stereoselective Peptidases

Samantha Bann; Ross Ballantine; Yong-Xin Li; Pei-Yuan Qian; Stephen Cochrane

doi:10.1021/acs.jmedchem.9b01078

A Chemical-Intervention Strategy to Circumvent Peptide Hydrolysis by D-Stereoselective Peptidases

Samantha Bann, Ross Ballantine, Yong-Xin Li, Pei-Yuan Qian, Stephen Cochrane

School of Chemistry and Chemical Engineering

Research output: Contribution to journal › Article

2 Citations (Scopus)

87 Downloads (Pure)

Abstract

D-Stereoselective peptidases that degrade non-ribosomal peptides (NRPs) were recently discovered and could have serious implications for the future of NRPs as antibiotics. Herein, we report chemical modifications that can be used to impart re-sistance to the D-peptidases BogQ and TriF. New tridecaptin A analogues were synthesized that retain strong antimicrobial activity and have significantly enhanced D-peptidase stability. In vitro assays confirmed that synthetic analogues retain the ability to bind to their cellular receptor, peptidoglycan intermediate lipid II.

Original language	English
Pages (from-to)	10466-10472
Journal	Journal of Medicinal Chemistry
Volume	62
Issue number	22
DOIs	https://doi.org/10.1021/acs.jmedchem.9b01078
Publication status	Published - 27 Nov 2019

Access to Document

10.1021/acs.jmedchem.9b01078Licence: CC BY

A Chemical-Intervention Strategy To Circumvent Peptide Hydrolysis by d-Stereoselective Peptidases
Copyright 2019 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
Final published version, 909 KBLicence: CC BY

Fingerprint Dive into the research topics of 'A Chemical-Intervention Strategy to Circumvent Peptide Hydrolysis by D-Stereoselective Peptidases'. Together they form a unique fingerprint.

Cite this

@article{c2762c66e4ac4fa6bb013962fa341059,

title = "A Chemical-Intervention Strategy to Circumvent Peptide Hydrolysis by D-Stereoselective Peptidases",

abstract = "D-Stereoselective peptidases that degrade non-ribosomal peptides (NRPs) were recently discovered and could have serious implications for the future of NRPs as antibiotics. Herein, we report chemical modifications that can be used to impart re-sistance to the D-peptidases BogQ and TriF. New tridecaptin A analogues were synthesized that retain strong antimicrobial activity and have significantly enhanced D-peptidase stability. In vitro assays confirmed that synthetic analogues retain the ability to bind to their cellular receptor, peptidoglycan intermediate lipid II.",

author = "Samantha Bann and Ross Ballantine and Yong-Xin Li and Pei-Yuan Qian and Stephen Cochrane",

year = "2019",

month = nov,

day = "27",

doi = "10.1021/acs.jmedchem.9b01078",

language = "English",

volume = "62",

pages = "10466--10472",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "22",

}

TY - JOUR

T1 - A Chemical-Intervention Strategy to Circumvent Peptide Hydrolysis by D-Stereoselective Peptidases

AU - Bann, Samantha

AU - Ballantine, Ross

AU - Li, Yong-Xin

AU - Qian, Pei-Yuan

AU - Cochrane, Stephen

PY - 2019/11/27

Y1 - 2019/11/27

N2 - D-Stereoselective peptidases that degrade non-ribosomal peptides (NRPs) were recently discovered and could have serious implications for the future of NRPs as antibiotics. Herein, we report chemical modifications that can be used to impart re-sistance to the D-peptidases BogQ and TriF. New tridecaptin A analogues were synthesized that retain strong antimicrobial activity and have significantly enhanced D-peptidase stability. In vitro assays confirmed that synthetic analogues retain the ability to bind to their cellular receptor, peptidoglycan intermediate lipid II.

AB - D-Stereoselective peptidases that degrade non-ribosomal peptides (NRPs) were recently discovered and could have serious implications for the future of NRPs as antibiotics. Herein, we report chemical modifications that can be used to impart re-sistance to the D-peptidases BogQ and TriF. New tridecaptin A analogues were synthesized that retain strong antimicrobial activity and have significantly enhanced D-peptidase stability. In vitro assays confirmed that synthetic analogues retain the ability to bind to their cellular receptor, peptidoglycan intermediate lipid II.

U2 - 10.1021/acs.jmedchem.9b01078

DO - 10.1021/acs.jmedchem.9b01078

M3 - Article

VL - 62

SP - 10466

EP - 10472

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 22

ER -